TRexBio to Present Late-Breaking Data at SID 2026 Supporting TNFR2 Agonism as a Therapeutic Strategy for Atopic Dermatitis ...
Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of Opzelura ® (ruxolitinib) cream in adults with moderate atopic dermatitis ...
In this episode, the panel considers safety questions surrounding OX40-targeted therapy in light of the Kaposi sarcoma (KS) ...
When my skin is angry and my perioral dermatitis is at its worst, I recommend Avène’s cicalfate+ restorative protective cream ...
Real Simple on MSN
This repair cream is the only thing that soothes my sensitive skin and keeps dermatitis at bay—and it's 30% off now
I happily buy it full-priced, but I’m stocking up while it’s on sale.
When confronted with chronic eczematous dermatitis, clinicians should try to differentiate between intrinsic (atopic dermatitis [AD]) and extrinsic (allergic or irritant contact dermatitis) causes. AD ...
What is contact dermatitis? Contact dermatitis is a reaction that occurs when something touches your skin and triggers a rash. The rash may appear right away or it could take some time to develop.
Bambusa expects to announce top line results from the four-week treatment study by the middle of 2026.
A survey of veterinarians shows that financial constraints are common among clients managing canine atopic dermatitis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results